Cargando…

Management of Hepatic Encephalopathy Associated with Advanced Liver Disease

Hepatic encephalopathy (HE) is a very prevalent condition in patients with advanced liver disease and has a high recurrence rate. The pathophysiology has a multifactorial origin where hyperammonaemia and inflammation become particularly relevant. There are no HE-specific diagnostic tests, and diagno...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Martínez, Rita, Diaz-Ruiz, Raquel, Poncela, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205788/
https://www.ncbi.nlm.nih.gov/pubmed/35536537
http://dx.doi.org/10.1007/s40261-022-01146-6
_version_ 1784729202620104704
author García-Martínez, Rita
Diaz-Ruiz, Raquel
Poncela, Marta
author_facet García-Martínez, Rita
Diaz-Ruiz, Raquel
Poncela, Marta
author_sort García-Martínez, Rita
collection PubMed
description Hepatic encephalopathy (HE) is a very prevalent condition in patients with advanced liver disease and has a high recurrence rate. The pathophysiology has a multifactorial origin where hyperammonaemia and inflammation become particularly relevant. There are no HE-specific diagnostic tests, and diagnosis is usually made by taking into account the presence of suggestive and compatible clinical symptoms, the existence of a predisposing liver condition and ruling out other causes with similar clinical manifestations. Once the diagnosis of HE is established, it is essential to carry out an adequate classification based on the underlying liver disease, the intensity of clinical manifestations, the temporal course of the disease and the presence or absence of precipitating factors. Treatment should be aimed at decreasing the duration, intensity and consequences of episodes, preventing recurrence and limiting the impact of the disease in patients and their relatives.
format Online
Article
Text
id pubmed-9205788
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-92057882022-06-19 Management of Hepatic Encephalopathy Associated with Advanced Liver Disease García-Martínez, Rita Diaz-Ruiz, Raquel Poncela, Marta Clin Drug Investig Review Article Hepatic encephalopathy (HE) is a very prevalent condition in patients with advanced liver disease and has a high recurrence rate. The pathophysiology has a multifactorial origin where hyperammonaemia and inflammation become particularly relevant. There are no HE-specific diagnostic tests, and diagnosis is usually made by taking into account the presence of suggestive and compatible clinical symptoms, the existence of a predisposing liver condition and ruling out other causes with similar clinical manifestations. Once the diagnosis of HE is established, it is essential to carry out an adequate classification based on the underlying liver disease, the intensity of clinical manifestations, the temporal course of the disease and the presence or absence of precipitating factors. Treatment should be aimed at decreasing the duration, intensity and consequences of episodes, preventing recurrence and limiting the impact of the disease in patients and their relatives. Springer International Publishing 2022-05-10 2022 /pmc/articles/PMC9205788/ /pubmed/35536537 http://dx.doi.org/10.1007/s40261-022-01146-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Review Article
García-Martínez, Rita
Diaz-Ruiz, Raquel
Poncela, Marta
Management of Hepatic Encephalopathy Associated with Advanced Liver Disease
title Management of Hepatic Encephalopathy Associated with Advanced Liver Disease
title_full Management of Hepatic Encephalopathy Associated with Advanced Liver Disease
title_fullStr Management of Hepatic Encephalopathy Associated with Advanced Liver Disease
title_full_unstemmed Management of Hepatic Encephalopathy Associated with Advanced Liver Disease
title_short Management of Hepatic Encephalopathy Associated with Advanced Liver Disease
title_sort management of hepatic encephalopathy associated with advanced liver disease
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205788/
https://www.ncbi.nlm.nih.gov/pubmed/35536537
http://dx.doi.org/10.1007/s40261-022-01146-6
work_keys_str_mv AT garciamartinezrita managementofhepaticencephalopathyassociatedwithadvancedliverdisease
AT diazruizraquel managementofhepaticencephalopathyassociatedwithadvancedliverdisease
AT poncelamarta managementofhepaticencephalopathyassociatedwithadvancedliverdisease